Semaglutide is a GLP-1 receptor agonist, available under the brand names Ozempic (for diabetes) and Wegovy (for weight loss)
Hernandez AF, Green JB, Janmohamed S, DAgostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S, Harmony Outcomes committees and investigators
The opposite is correct for the cation, which like a positive charged protein exchanges with sodium or potassium ion
By combining these analyses, we provide scientifically defensible proof of sameness
Finally, this study had a fairly short follow-up time, so it does not necessarily show how GLP-1RAs affect long-term depression risk
GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity